Abiomed to Host Investor Call on Heart Failure Opportunity With Impella 5.5 and Impella BTR Heart Pumps Business Wire - Tue Jun 14, 3:30PM CDT
Business Wire
Tue Jun 14, 3:30PM CDT
Abiomed, Inc . (NASDAQ: ABMD) today announced that it will host an investor call on the heart failure opportunity with the Impella 5.5 and future Impella BTR heart pumps on June 24, 2022 from 2:30 p.m. – 3:30 p.m. ET. The event will include...
Abiomed to Present (Live) at the William Blair 42nd Annual Growth Stock Conference Business Wire - Tue May 31, 6:00AM CDT
Business Wire
Tue May 31, 6:00AM CDT
Abiomed, Inc . (NASDAQ: ABMD), a leader in breakthrough heart, lung and kidney support technologies, today announced that Michael R. Minogue, Chairman, President and Chief Executive Officer, will present (live) at the William Blair 42 nd Annual...
SCAI 2022 Scientific Sessions Highlight Impella Research, Advancements to Improve Cardiogenic Shock Outcomes Business Wire - Wed May 18, 7:03AM CDT
Business Wire
Wed May 18, 7:03AM CDT
Abiomed (NASDAQ: ABMD), a leader in breakthrough heart, lung and kidney support technologies, will feature the most recent Impella research and technological advances aimed at improving outcomes for acute myocardial infarction cardiogenic shock...